Progressive Investment Management Corp Abbott Laboratories Transaction History

Progressive Investment Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $19,661 - $24,067	-218 Reduced 10.45%	1,869 $205,000
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $1,549 - $1,824	-16 Reduced 0.76%	2,087 $211,000
Q4 2022 Jan 30, 2023	SELL	$95.06 - $111.52 $25,666 - $30,110	-270 Reduced 11.38%	2,103 $230,000
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $3,420 - $4,171	-30 Reduced 1.25%	2,373 $281,000
Q4 2021 Feb 03, 2022	SELL	$115.53 - $141.46 $59,497 - $72,851	-515 Reduced 17.65%	2,403 $338,000
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $116,660 - $129,060	1,000 Added 52.14%	2,918 $345,000
Q3 2020 Oct 29, 2020	BUY	$91.64 - $111.29 $175,765 - $213,454	1,918 New	1,918 $209,000

3,303

1.34B

9.84M

8.59M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Progressive Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Progressive Investment Management Corp with notifications on news.